Min-soo Han

Title: Min-soo Han: Innovator in Antidepressant Composition

Introduction

Min-soo Han is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antidepressant compositions. His innovative work focuses on addressing psychiatric disorders through novel chemical compounds.

Latest Patents

Min-soo Han holds a patent for an azetidine derivative and an antidepressant composition that includes this compound. The invention relates to a unique azetidine derivative or a pharmaceutically acceptable salt thereof. This antidepressant agent is designed for the prevention or treatment of psychiatric disorders. The azetidine derivative functions as a triple reuptake inhibitor, effectively inhibiting the reuptake of neurotransmitters such as dopamine, serotonin, and norepinephrine simultaneously. This innovative approach has the potential to enhance treatment options for individuals suffering from mental health issues.

Career Highlights

Min-soo Han is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in the pharmaceutical sector. His work is characterized by a commitment to advancing mental health treatments through scientific innovation.

Collaborations

Some of his notable coworkers include Hoh-Gyu Hahn and Kee-Dal Nam, who contribute to the collaborative efforts in research and development at the Korea Institute of Science and Technology.

Conclusion

Min-soo Han's contributions to the field of antidepressant compositions highlight his role as an innovator in mental health treatment. His patented work on azetidine derivatives represents a significant advancement in the pharmaceutical industry.